EGFR and neoplasm: In tumor cells, there was elevated EGFR immunoreactivity in most samples (Figure 5D), decreased membranous staining and increased cytoplasmic/nuclear staining of β-catenin (Figure 5E), and positive staining for cyclin D1 (Figure 5F).